A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
The Strategic Value of Pharmaceutical Competitive Intelligence
In pharma, the competitive landscape evolves rapidly. This post outlines how strategic competitive intelligence helps life science teams anticipate market changes, monitor rivals, and inform smarter launch, pricing, and portfolio decisions.
Strategic Intelligence Equips Cardiovascular Client to Navigate Market Disruption from New Entrants and Generics
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
Innovative Pharma Company Navigates Evolving Pain Market with Targeted Competitive Insights
To navigate a fast-changing chronic pain market, a leading pharma company partnered with Sedulo for targeted competitive intelligence, gaining timely insights that shaped strategy across brand, CI, and market access teams.
Facing Headwinds: How CI Teams Can Navigate Shifting Pharma Market Trends
In unpredictable markets, resilience isn’t optional, it’s essential. This piece explores how economic and regulatory shocks test corporate strategies and why embedding agility and cross-functional coordination into CI frameworks empowers companies to weather turbulence and stay nimble.
Preparing for Competitive Market Entry through Strategic Wargaming
Background A leading medical aesthetics company sought to prepare for a significant competitive disruption: the anticipated entry of a rival global manufacturer into the U.S. market. The client understood that this competitor’s entry would be accompanied by assertive marketing, differentiated product claims, and a well-funded commercial strategy, threatening to erode its market share and customer loyalty. To defend its position …
Strategic Benchmarking in the Gastrointestinal Medical Device Market
The Situation A global medical device manufacturer sought to deepen its competitive intelligence in the gastrointestinal (GI) space. As market dynamics evolved rapidly, driven by innovation in imaging systems, increased digitization, and shifting regulatory environments, the client aimed to benchmark its own R&D and sales strategies against key competitors in the GI medical device category. They needed to understand: How …
What the Best Pharma Competitive Intelligence Companies All Have in Common
In a high-stakes, fast-moving pharma landscape, the best competitive intelligence partners do more than deliver data, they drive strategy. This post outlines eight essential traits that set leading CI firms apart, based on real-world buyer insights and evolving industry demands.
Pharma CI Conference 2024: Comprehensive Summary Report
At the Pharma CI Conference (Sept 25–26, 2024), leaders discussed how shifts like the IRA’s impact on drug pricing, AI in R&D, and shifting regulatory regimes are reshaping life sciences CI. Read this summary to grasp the conference’s breakout trends and strategic implications.
Pharmaceutical Primary Intelligence to Enhance Competitive Landscape Development
Pharmaceutical companies need more than public data to stay ahead. Learn how integrating pharmaceutical primary intelligence fills critical gaps and uncovers real-time competitive insights.